Discontinued — last reported Q1 '18
Humana Available-for-Sale Debt Securities - Amortized Cost (1-5 Years) increased by 1.3% to $4.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.9%, from $5.34B to $4.76B.
Changes in this bucket reflect the company's medium-term interest rate outlook and its strategy for balancing yield against market volatility.
This metric represents the amortized cost of available-for-sale debt securities with maturity dates ranging from one to...
Standard maturity bucket used by insurance companies to demonstrate asset-liability management (ALM) positioning.
afs_debt_securities_amortized_cost_1_to_5y| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $4.12B | $4.45B | $5.40B | $5.29B | $5.67B | $5.34B | $5.39B | $4.70B | $4.76B |
| QoQ Change | — | +8.2% | +21.3% | -2.1% | +7.1% | -5.7% | +0.8% | -12.8% | +1.3% |
| YoY Change | — | — | +31.2% | +18.8% | — | -1.1% | +1.8% | -17.2% | -10.9% |